Evan French

机构：Virginia Commonwealth University · ORCID：0000-0002-5809-5810

发表论文 64 篇 · 总被引 1064 次 · h-index 14

代表论文

• An overview of biomedical entity linking throughout the years (2022 · Journal of Biomedical Informatics · 被引 62)
• Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2023 · The Lancet Diabetes & Endocrinology · 被引 42)
• Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial (2024 · The Lancet Child & Adolescent Health · 被引 40)
• The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls (2022 · American Journal of Transplantation · 被引 37)
• Higher Rate of Spontaneous Bacterial Peritonitis Recurrence With Secondary Spontaneous Bacterial Peritonitis Prophylaxis Compared With No Prophylaxis in 2 National Cirrhosis Cohorts (2024 · The American Journal of Gastroenterology · 被引 32)
• Who is pregnant? Defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C) (2023 · JAMIA Open · 被引 23)